CrystalsFirst GmbH unlocks the potential of new-era medicines using advanced lab technology and AI. CrystalsFirst's MAGNET platform overcomes current limitations of small molecule drug discovery. Their proprietary structural biology technology detects molecular magnets and generative AI/Machine Learning identifies novel molecules and druggable binding pockets for difficult targets.